Episode 101: In the Clinic - The future of Adjuvant treatment in kidney cancer with Dr Will Ince and Dr Naveen Vasudev

Send us Fan Mail (buzzsprout.com/2342317/fan_mail/new)
Join us as we complete our tour of the adjuvant kidney cancer treatment space.
We are joined again by the excellent Dr Will Ince from Cambridge and Dr Naveen Vasudev from Leeds!
In our last episode we discussed KEYNOTE 564 and the RAMPART study and where this places immunotherapy in adjuvant kidney cancer.
In this episode we discuss the LITESPARK 022 trial and the addition of Belzutifan to Pembrolizumab in adjuvant kidney cancer treatment.
We also discuss the potential for KIM-1 to be used as a biomarker to highlight those higher risk patients that may benefit from adjuvant immunotherapy.
This is an exciting time for adjuvant treatment in kidney cancer.
All this as Will continues to misbehave to amuse himself!!
We hope you enjoy!